551 related articles for article (PubMed ID: 30635290)
1. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
[TBL] [Abstract][Full Text] [Related]
2. Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning.
Zhao W; Yang J; Ni B; Bi D; Sun Y; Xu M; Zhu X; Li C; Jin L; Gao P; Wang P; Hua Y; Li M
Cancer Med; 2019 Jul; 8(7):3532-3543. PubMed ID: 31074592
[TBL] [Abstract][Full Text] [Related]
3. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
4. Transfer learning-based PET/CT three-dimensional convolutional neural network fusion of image and clinical information for prediction of EGFR mutation in lung adenocarcinoma.
Shao X; Ge X; Gao J; Niu R; Shi Y; Shao X; Jiang Z; Li R; Wang Y
BMC Med Imaging; 2024 Mar; 24(1):54. PubMed ID: 38438844
[TBL] [Abstract][Full Text] [Related]
5. Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma.
Weng L; Xu Y; Chen Y; Chen C; Qian Q; Pan J; Su H
Clin Transl Oncol; 2024 Jun; 26(6):1438-1445. PubMed ID: 38194018
[TBL] [Abstract][Full Text] [Related]
6. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
Li M; Zhang L; Tang W; Jin YJ; Qi LL; Wu N
Eur Radiol; 2019 Jun; 29(6):2989-2997. PubMed ID: 30367185
[TBL] [Abstract][Full Text] [Related]
7. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
8. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results.
Zhang G; Cao Y; Zhang J; Zhao Z; Zhang W; Zhou J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1169-1178. PubMed ID: 32980961
[TBL] [Abstract][Full Text] [Related]
10. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
Chen Y; Yang Y; Ma L; Zhu H; Feng T; Jiang S; Wei Y; Wang T; Sun X
Eur J Radiol; 2019 Mar; 112():44-51. PubMed ID: 30777218
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: A propensity score matching study.
Suh YJ; Lee HJ; Kim YJ; Kim KG; Kim H; Jeon YK; Kim YT
Lung Cancer; 2018 Sep; 123():52-59. PubMed ID: 30089595
[TBL] [Abstract][Full Text] [Related]
12. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
[TBL] [Abstract][Full Text] [Related]
13. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
[TBL] [Abstract][Full Text] [Related]
14. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
[No Abstract] [Full Text] [Related]
15. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
16. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
[TBL] [Abstract][Full Text] [Related]
17. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K
Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
[TBL] [Abstract][Full Text] [Related]
20. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature.
Wang X; Kong C; Xu W; Yang S; Shi D; Zhang J; Du M; Wang S; Bai Y; Zhang T; Chen Z; Ma Z; Wang J; Dong G; Sun M; Yin R; Chen F
Thorac Cancer; 2019 Oct; 10(10):1904-1912. PubMed ID: 31414580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
